CTNM - Contineum Therapeutics Inc Profit before interest, taxes and amortization

Graphic logo of Contineum Therapeutics (CTNM)

Contineum Therapeutics, Inc. (CTNM) focuses on developing small molecules for CNS therapies, investing in scientific potential. However, the lack of sales and reliance on grants create significant risks. The EBITDA breakdown clearly confirms the financial condition, where 0.00 reflects the latest value of the metric. Meanwhile, the company strictly adheres to environmental regulations regarding the disposal of laboratory waste.

CTNM Contineum Corp: Profit before payment of interest, taxes and amortization in the range 11/23/2025 - 11/15/2026

Summary analytical data breakdowns for Contineum Pharma (CTNM)

- share price and expert price forecast:
Share Price Contineum Therapeutics, Inc.|CTNM - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Contineum Pharma|CTNM - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Contineum Therapeutics|CTNM - Company Book Value|Market Value to Book Value contineum-tx.com|CTNM - Aggregate Company Assets
- company total debt and liquidity indicators:
Debt to Capital Contineum Therapeutics, Inc.|CTNM - Long-Term Debt to Equity|Short-Term Debt to Equity Contineum Corp|CTNM - Company Debts|Debts to Book Value Contineum Therapeutics, Inc.|CTNM - Company Long-Term Debts|Short-Term Indebtedness Contineum Therapeutics|Immediate Liquidity contineum-tx.com
- business earnings and investment ratios data:
CTNM - Net Profit|Future Profit Contineum Therapeutics, Inc.|CTNM - Price to Earnings Ratio|Projected Price to Earnings Ratio Contineum Therapeutics Inc|CTNM - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Contineum Pharma|CTNM - Operating profit before deduction of amortization|Earnings per share for the last four quarters Contineum Therapeutics|CTNM - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months contineum-tx.com|CTNM - Earnings per share growth in current year|Projected earnings per share growth rate for next year Contineum Therapeutics, Inc.
- sales and revenue data:
CTNM - Revenue and Sales Volume|Company Expected Sales Volume Contineum Therapeutics|CTNM - Market Cap to Revenue|Forward P/S Multiple Contineum Therapeutics Inc|CTNM - Sales Growth YoY (Last Twelve Months)
Analysis of all company metrics:Contineum Therapeutics, Inc.
Manufactured product of Contineum Therapeutics Inc

This metric reflects net cash flow from operating activities, excluding the impact of depreciation and taxes to assess the business's actual ability to generate cash. Analyzing the absolute operating profit of Contineum Therapeutics, Inc. (CTNM) in monetary terms allows for the timely detection of liquidity shortages, which is critical for Contineum Therapeutics, Inc. (CTNM) amid fierce competition with biotech behemoths and the high risks associated with clinical trials.

Who Contineum Therapeutics, Inc. competes with

JAZZ: Operating profit before amortization|Cytokinetics Corp - Operating profit EBITDA|Profit before interest, taxes and amortization PTC Therapeutics Corp|SRRK (Scholar Rock, Inc.) - Operating profit before deduction of amortization|Centessa Corp (CNTA) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Dyne Therapeutics Inc|EWTX: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Rapport Corp (RAPP)|ALMS - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Kempharm ZVRA|Larimar Corp - Profit before payment of interest, taxes and amortization|CAPR - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Entrada Therapeutics|PTHS: Operating profit EBITDA|Operating profit before depreciation charges MediciNova, Inc. MNOV|Profit before payment of interest, taxes and amortization Serina Pharma|Profit before interest, taxes and amortization BioXcel BTAI|Profit before payment of interest, taxes and amortization ProMIS Neurosciences Inc. (PMN)|Operating profit EBITDA Apimeds Pharmaceuticals, Inc. (APUS)|Operating profit EBITDA AEON (AEON Biopharma, Inc.)|NLS Pharmaceutics AG - Profit before payment of interest, taxes and amortization|BNOX - Profit before payment of interest, taxes and amortization|HUGE (FSD Pharma Inc.) - Operating profit before amortization|RETA (Reata) - Operating profit before deduction of amortization